Abstract
Differences in quality of care may contribute to health disparities in systemic lupus erythematosus (SLE). Studies show low physician adherence rates to the SLE quality indicators but do not assess physician perception of SLE quality indicators or quality improvement. Using a cross-sectional survey of rheumatologists in the southeastern USA, we assessed the perception and involvement of rheumatologists in quality improvement and the SLE quality indicators. Using electronic mail, an online survey of 32 questions was delivered to 568 rheumatologists. With a response rate of 19% (n = 106), the majority of participants were male, Caucasian, with over 20 years of experience, and seeing adult patients in an academic setting. Participants had a positive perception toward quality improvement (81%) with a majority responding that the SLE quality indicators would significantly impact quality of care (54%). While 66% of respondents were familiar with the SLE quality indicators, only 18% of respondents reported using them in everyday practice. The most commonly reported barrier to involvement in quality improvement and the SLE quality indicators was time. Rheumatologists had a positive perception of the SLE quality indicators and agreed that use of the quality indicators could improve quality of care in SLE; however, they identified time as a barrier to implementation. Future studies should investigate methods to increase use of the SLE quality indicators.
Similar content being viewed by others
References
Demas KL, Costenbader KH (2009) Disparities in lupus care and outcomes. Curr Opin Rheumatol 21:102–109
Institute of Medicine Committee on Quality of Health Care in America (2001) Crossing the quality chasm: a new health system for the 21st century. National Academy, Washington, DC
Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, Yelin E (2009) A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 61:370–377
Campbell SM, Braspenning J, Hutchinson A, Marshall MN (2003) Research methods used in developing and applying quality indicators in primary care. BMJ 326:816–819
Yazdany J, Trupin L, Schmajuk G, Katz PP, Yelin EH (2014) Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the lupus outcomes study. BMJ Qual Saf 23:659–666
Yazdany J, Feldman CH, Liu J, Ward MM, Fischer MA, Costenbader KH (2014) Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Arthritis Care Res (Hoboken) 66:617–624
Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopalis P, Yazdany J (2010) Osteoporosis screening, prevention and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res (Hoboken) 62:993–1001
Demas K, Keenan B, Solomon D, Yazdany J, Costenbader KH (2010) Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Semin Arthritis Rheum 40:193–200
Yazdany J, Trupin L, Tonner C, Dudley RA, Zell J, Panopalis P, Schmajuk G, Julian L, Katz P, Criswell LA, Yelin E (2012) Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. J Gen Intern Med 27:1326–1333
Quinzanos I, Davis L, Keniston A, Nash A, Yazdany J, Fransen R, Hirsh JM, Zell J (2015) Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. Lupus 24:203–209
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381
Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, Bilker WB, Saag KG (2004) Quality of care indicators for gout management. Arthritis Rheum 50:937–943
Saag KG, Olivieri JJ, Patino F, Mikuls TR, Allison JJ, MacLean CH (2004) Measuring quality in arthritis care: the Arthritis Foundation’s quality indicator set for analgesics. Arthritis Rheum 51:337–349
Pencharz JN, MacLean CH (2004) Measuring quality in arthritis care: the Arthritis Foundation’s quality indicator set for osteoarthritis. Arthritis Rheum 51:538–548
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG (2005) Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 44:1038–1042
Singh JA, Hodges JS, Toscano JP, Asch SM (2007) Quality of care for gout in the US needs improvement. Arthritis Rheum 57:822–829
Singh JA (2009) Quality of life and quality of care for patients with gout. Curr Rheumatol Rep 11:154–160
Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK, Frank L, Waltrip R, Maroli A, Huang B, Sundy JS (2009) Quality of life and disability in patients with treatment-failure gout. J Rheumatol 36:1041–1048
Anderson E, Bajaj P, Raghavan S, Patnaik A, Roppelt H (2016) Assessment of American College of Rheumatology-endorsed quality indicators in rheumatoid arthritis patients: a quality improvement initiative. J Clin Rheumatol 22:63–67
Lim C, Cheung MC, Franco B, Dharmakulasselan L, Chong E, Iyngarathasan A, Singh S (2014) Quality improvement: an assessment of participation and attitudes of medical oncologists. J Oncol Pract 10:e408–e414
Kirchhoff AC, Hart G, Campbell EG (2014) Rural and urban primary care physician professional beliefs and quality improvement behaviors. J Rural Health 30:235–243
Candas B, Jobin G, Dube C, Tousignant M, Abdejelil AB, Grenier S, Gagnon MP (2016) Barriers and facilitators to implementing continuous quality improvement programs in colonoscopy services: a mixed methods systematic review. Endosc Int Open 4:E118–E133
Acknowledgments
We would like to acknowledge the support of the following state societies: Alabama Rheumatology Society, Tennessee Rheumatology Society, South Carolina Rheumatism Society, and the Kentuckiana Rheumatology Alliance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial support
Supported by grants NIH/NIAMS 5 T32 AR059039-05 (Barnado), NIH/NICHD 5 K12HD043483-12 (Barnado), K23AR064768 (Chung), Rheumatology Research Foundation (Chung), NCATS/NIH UL1 TR000445.
Disclosures
None.
Ethical standards
Approval for the study was given by the Institutional Review Board of Vanderbilt University Medical Center [# 150649]. By completing the online survey, respondents gave electronic informed consent.
Rights and permissions
About this article
Cite this article
Casey, C., Chung, C.P., Crofford, L.J. et al. Rheumatologists’ perception of systemic lupus erythematosus quality indicators: significant interest and perceived barriers. Clin Rheumatol 36, 97–102 (2017). https://doi.org/10.1007/s10067-016-3487-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3487-3